EP2825542
Stillar af lifrar X viðtökum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2013EP published:
14.9.2016EP application number:
13712103.4
EP translation filed:
12.12.2016Grant published:
15.1.2017EPO information:
European Patent Register
Max expiry date:
13.3.2033Expiry date:
13.3.2022
Title:
LIVER X RECEPTOR MODULATORS
Timeline
Today
14.3.2013EP application
14.9.2016EP Publication
12.12.2016Translation submitted
15.1.2017Registration published
13.3.2022Expires
Owner
Name:
Vitae Pharmaceuticals, Inc.Address:
502 West Office Center Drive, 19034, Fort Washington, PA, US
Inventor
Name:
DONG, ChengguoAddress:
Staten Island, NY, US
Name:
FAN, YiAddress:
Doylestown, PA, US
Name:
LEFTHERIS, KaterinaAddress:
San DiegoCalifornia, US
Name:
LOTESTA, StephenAddress:
Burlington, NJ, US
Name:
SINGH, Suresh, B.Address:
Kendall Park, NJ, US
Name:
TICE, ColinAddress:
Ambler, PA, US
Name:
ZHAO, WeiAddress:
North PotomacMaryland, US
Name:
ZHENG, YajunAddress:
Hockessin, DE, US
Name:
ZHUANG, LinghangAddress:
Chalfont, PA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261612063 PDate:
16.3.2012Country:
US
Classification
Categories:
C07D 487/04, A61K 31/5025, A61P 3/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 25.4.2017
Expires: 13.3.2018
Payer: Árnason Faktor
Number: 6
Paid: 20.2.2018
Expires: 13.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 19.2.2019
Expires: 13.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 26.2.2020
Expires: 13.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.2.2021
Expires: 13.3.2022
Payer: Sigurjónsson & Thor ehf.